AI-based FFRangio software performs comparably to invasive pressure wire methods for evaluating coronary artery disease in a major international clinical trial.
Key Details
- 1FFRangio uses AI and 3D modeling from coronary angiograms to assess blood flow restrictions caused by artery plaques.
- 2The ALL-RISE trial enrolled 1,930 patients across five countries, comparing FFRangio with invasive wire-based pressure measurements.
- 3After one year, primary outcome events occurred in 6.9% of FFRangio patients versus 7.1% in the wire-based group.
- 4FFRangio is minimally invasive, faster, and eliminates the need for extra wires, catheters, or medication.
- 5The study was supported by CathWorks, Ltd., and results were published in the New England Journal of Medicine.
- 6Limitations include the trial not being blinded and exclusion of patients with prior coronary artery bypass surgery.
Why It Matters
This supports the viability of AI-driven imaging analysis as a less invasive, equally effective alternative to traditional procedures in coronary physiology assessment, potentially accelerating adoption and improving patient care efficiency in interventional cardiology.
Source
EurekAlert
Related News
•EurekAlert
Deepfake X-rays Deceive Radiologists and AI Models in Recent Study
Radiologists and leading AI models struggle to distinguish AI-generated deepfake X-ray images from authentic radiographs, according to a recent Radiology journal study.
•EurekAlert
Metasurface-Based Optical AI Achieves Breakthroughs in Scalable Medical Imaging
Researchers introduced a metasurface-based optical learning machine (MOLM) that achieves scalable, high-performance AI for imaging tasks including radiology and pathology.
•EurekAlert
AI Uses Routine Mammograms to Predict Women's Heart Disease Risk
AI can use mammograms to predict the risk of serious cardiovascular disease in women by quantifying breast arterial calcification.